Technical Analysis for AMLX - Amylyx Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
B 20.29 -4.65% -0.99
AMLX closed down 4.65 percent on Thursday, January 20, 2022, on 42 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A N/A
Historical AMLX trend table...

Date Alert Name Type % Chg
NR7 Range Contraction 0.00%
Inside Day Range Contraction 0.00%
New 52 Week Closing High Bullish -4.65%
Multiple of Ten Bullish Other -4.65%
Hot IPO Pullback Bullish Swing Setup 4.86%
Multiple of Ten Bearish Other 4.86%
Bearish Engulfing Bearish -1.55%
Inside Day Range Contraction -1.55%
New 52 Week Closing High Bullish -3.43%
New 52 Week High Strength -3.43%
Older End-of-Day Signals for AMLX ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Possible NR7 about 14 hours ago
Possible Inside Day about 14 hours ago
Down 5% about 16 hours ago
60 Minute Opening Range Breakdown about 16 hours ago
Gap Down Closed about 18 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Amylyx Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases in the United States and Canada. The company is developing AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and tauroursodeoxycholic acid for the treatment of ALS and other neurodegenerative diseases. It is also developing products for Wolfram syndrome and Alzheimer's diseases. The company was founded in 2013 and is headquartered in Cambridge, Massachusetts.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Life Sciences Pharmaceutical Alzheimer's Disease Neurodegenerative Diseases Amyotrophic Lateral Sclerosis Nervous System Apoptosis

Is AMLX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 23.16
52 Week Low 16.0
Average Volume 468,469
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 0.00
10-Day Moving Average 0.00
Average True Range 0.00
ADX 0.0
+DI 0.00
-DI 0.00
Chandelier Exit (Long, 3 ATRs) N/A
Chandelier Exit (Short, 3 ATRs) N/A
Upper Bollinger Bands 0.00
Lower Bollinger Band 0.00
Percent B (%b) 0.0
BandWidth 0.00
MACD Line 0.00
MACD Signal Line 0.00
MACD Histogram 0.0
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 22.18
Resistance 3 (R3) 22.34 21.88 21.87
Resistance 2 (R2) 21.88 21.40 21.80 21.76
Resistance 1 (R1) 21.08 21.10 20.85 20.92 21.65
Pivot Point 20.62 20.62 20.50 20.54 20.62
Support 1 (S1) 19.82 20.14 19.59 19.66 18.93
Support 2 (S2) 19.36 19.84 19.28 18.82
Support 3 (S3) 18.56 19.36 18.72
Support 4 (S4) 18.40